Solving Kids' Cancer UK with 5 charity partners launches £500,000 project in refractory neuroblastoma research
Today, Solving Kids’ Cancer UK, partnered with 5 other parent-led charities have awarded £500,000 to pre-clinical research into combination antibody therapies for chemotherapy-resistant neuroblastoma.
From lab bench to Solving Kids' Cancer: Introducing Research Officer, Leah
Research Officer, Leah, shares her journey from Cancer Biologist to charity research.
Solving Kids’ Cancer UK Care & Connect Family Support Bags
We are delighted to launch our Solving Kids’ Cancer UK Care & Connect Family Support Bags.
Cross-party MPs back calls for a UK-led vaccine trial to help children with cancer
Today Solving Kids’ Cancer UK has joined Kim Leadbeater, Labour MP for Batley and Spen, and Tom Tugendhat, Conservative MP for Tonbridge and Malling, at a roundtable of experts to advise on efforts to secure UK-led vaccine trials for children with cancer.
Research update- June 2022
There are exciting things ahead with the upcoming launch of our new 5-year strategy and a growing research team
The Big Love Fund
We are privileged to launch the BIG LOVE FUND, inspired by the story of Luke Wiltshire, on what would have been Luke’s 24th birthday. We have launched this new fund to help support more children and young people like Luke.
Solving Kids' Cancer UK Response to Debate on Childhood Cancer Outcomes
On 25th April Caroline Dinenage MP for Gosport brought forward a debate on Childhood Cancer Outcomes to the House of Commons. We are grateful that this ever-important topic has been brought to the House.
Bent's Garden & Homes raises over £44,000 for Solving Kids' Cancer UK as their Charity of the Year
We are so grateful to our 2021 Charity of the Year partners Bent’s Garden & Homes, their colleagues and customers for raising an astonishing £44,597!
Chair of Trustees leads patient advocate authorship on important special report discussing the use of high-dose chemotherapy in the treatment of high-risk neuroblastoma.
This week five patient advocate authors, led by SKC Chair Nick Bird, were published in the leading journal Pediatric Blood and Cancer.
